Company profile LPCN
There is not enough data for Lipocine (LPCN) stock to provide analysis
There is not enough data for Lipocine (LPCN) stock to provide correlation calculation
There is not enough data for Lipocine (LPCN) stock to provide analysis
Google Trends for Lipocine news
Q4 -100.0% YoY, nan% QoQ | Q1 inf% YoY, inf% QoQ | Correlation: 0.63
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Lipocine news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 88 inf% QoQ | 52 -40.9% QoQ | 35 -32.7% QoQ |
| 2020 | 39 inf% YoY 11.4% QoQ | 62 -29.5% YoY 59.0% QoQ | 387 644.2% YoY 524.2% QoQ | 128 265.7% YoY -66.9% QoQ |
| 2021 | 265 579.5% YoY 107.0% QoQ | 82 32.3% YoY -69.1% QoQ | 114 -70.5% YoY 39.0% QoQ | 57 -55.5% YoY -50.0% QoQ |
| 2022 | 33 -87.5% YoY -42.1% QoQ | 67 -18.3% YoY 103.0% QoQ | 93 -18.4% YoY 38.8% QoQ | 106 86.0% YoY 14.0% QoQ |
| 2023 | 82 148.5% YoY -22.6% QoQ | 31 -53.7% YoY -62.2% QoQ | 17 -81.7% YoY -45.2% QoQ | 57 -46.2% YoY 235.3% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Lipocine news was 6.88 per week. The last year interest of Lipocine news compared to the last 5 years has changed by -47.67%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 6.82%.
There is not enough data for Lipocine pipeline to provide analysis
There is not enough data for Lipocine pipeline to provide correlation calculation
There is not enough data for Lipocine pipeline to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Lipocine TLANDO expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 80 | 83 3.8% QoQ | 16 -80.7% QoQ | 84 425.0% QoQ |
| 2020 | 56 -30.0% YoY -33.3% QoQ | 56 -32.5% YoY 0.0% QoQ | 83 418.8% YoY 48.2% QoQ | 100 19.0% YoY 20.5% QoQ |
| 2021 | 158 182.1% YoY 58.0% QoQ | 14 -75.0% YoY -91.1% QoQ | 57 -31.3% YoY 307.1% QoQ | 42 -58.0% YoY -26.3% QoQ |
| 2022 | 140 -11.4% YoY 233.3% QoQ | 0 -100.0% YoY -100.0% QoQ | 49 -14.0% YoY inf% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 55 -60.7% YoY inf% QoQ | 105 inf% YoY 90.9% QoQ | 75 53.1% YoY -28.6% QoQ | 50 inf% YoY -33.3% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Lipocine TLANDO was 4.99 per week. The last year interest of Lipocine TLANDO compared to the last 5 years has changed by 9.82%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by -10.6%.
There is not enough data for Lipocine testosterone replacement therapy to provide analysis
There is not enough data for Lipocine testosterone replacement therapy to provide correlation calculation
There is not enough data for Lipocine testosterone replacement therapy to provide analysis
There is not enough data for Lipocine CNS disorders to provide analysis
There is not enough data for Lipocine CNS disorders to provide correlation calculation
There is not enough data for Lipocine CNS disorders to provide analysis
There is not enough data for Lipocine postpartum depression to provide analysis
There is not enough data for Lipocine postpartum depression to provide correlation calculation
There is not enough data for Lipocine postpartum depression to provide analysis
There is not enough data for Lipocine testosterone laurate to provide analysis
There is not enough data for Lipocine testosterone laurate to provide correlation calculation
There is not enough data for Lipocine testosterone laurate to provide analysis
There is not enough data for Lipocine cirrhosis management to provide analysis
There is not enough data for Lipocine cirrhosis management to provide correlation calculation
There is not enough data for Lipocine cirrhosis management to provide analysis
There is not enough data for Lipocine non-alcoholic steatohepatitis to provide analysis
There is not enough data for Lipocine non-alcoholic steatohepatitis to provide correlation calculation
There is not enough data for Lipocine non-alcoholic steatohepatitis to provide analysis